Previous 10 | Next 10 |
2023-07-31 08:37:42 ET China Natural Resources ( NASDAQ: CHNR ) +49% . Allarity Therapeutics ( ALLR ) +31% . Barnes & Noble Education ( BNED ) +17% . Spero Therapeutics ( SPRO ) +13% Announces Special Protocol Assessment Agreement with FDA...
BOSTON and SYDNEY (July 31, 2023) — Allarity Therapeutics, Inc. (Nasdaq: ALLR) (“Allarity”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP ® companion diagnostics for personalized cancer care, and Detsa...
New appointments bring therapeutic development expertise and proven leadership to support continu ed progress of Allarity’s mult i ple oncology clinical programs BOSTON (July 24, 2023) — Allarity Therapeutics, Inc. (Allarit...
2023-07-10 10:03:22 ET Gainers: NanoString Technologies ( NSTG ) +23% . NeuroOne Medical Technologies Corporation ( NMTC ) +21% . Novavax ( NVAX ) +18% . Sientra ( SIEN ) +15% . Losers: Outset Medical ( OM ) -12% . PainRe...
2023-07-07 10:07:00 ET Gainers: Castle Biosciences ( CSTL ) +43% . CareDx ( CDNA ) +20% . COMPASS Pathways ( CMPS ) +9% . TG Therapeutics ( TGTX ) +9% . KalVista Pharmaceuticals ( KALV ) +8% . Losers: PainReform ( P...
2023-07-06 13:08:25 ET Gainers: EdtechX Holdings Acquisition ( EDTX ) +40% . Mullen Automotive ( MULN ) +35% . Genius Sports Limited ( GENI ) +21% . Incannex Healthcare Limited ( IXHL ) +19% . Sweetgreen ( SG ) +18% . urban-g...
2023-07-06 06:22:56 ET Allarity Therapeutics ( NASDAQ: ALLR ) prices public offering of 2.44M common shares and common warrants to purchase up to 2.44M common shares at an effective combined price of $4.50 per share and common warrant for aggregate gross proceeds of ~$11M. The...
BOSTON, MA (July 6, 2023) — Allarity Therapeutics, Inc. (Nasdaq: ALLR) (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for personalized canc...
Allarity Therapeutics Inc (NASDAQ: ALLR) is one of today's top gainers. The company's shares are currently up 56.51% on the day to $9.86. Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnosti...
Boston , MA (July 5, 2023) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (Nasdaq: ALLR), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP ® companion diagnostics for p...
News, Short Squeeze, Breakout and More Instantly...
Allarity Therapeutics Inc. Company Name:
ALLR Stock Symbol:
NASDAQ Market:
Allarity Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Sangamo Therapeutics Inc. (SGMO) rose 50.7% to $0.604699 on volume of 90,844,210 shares Selina Hospitality PLC (SLNA) rose 7.7% to $0.028 on volume of 57,431,570 shares NuZee Inc. (NUZE) rose 260.1% to $3.7094 on volume of 53,639,595 ...
Boston (July 24, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, encourages its stockholders to participate actively in the ...
Current Cash Balance of $20 million Expected to Provide Runway Into 2026 Allarity to Pause Use of ATM Cap Table Successfully Cleaned Up Allarity’s Stenoparib Shows Extended Duration of Phase 2 Clinical Benefit Boston (July 22, 2024)—Allarity The...